New India Chemical Pharmaceutical Works Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 31-12-2024
- Paid Up Capital ₹ 0.94 M
as on 31-12-2024
- Company Age 70 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
About New India Chemical Pharmaceutical Works
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.94 M, as per Ministry of Corporate Affairs (MCA) records.
Sunit Agarwal, Dharm Agarwal, and Priya Agarwal serve as directors at the Company.
- CIN/LLPIN
U24111UR1954PTC002553
- Company No.
002553
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Oct 1954
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at New India Chemical Pharmaceutical Works?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharm Agarwal  | Managing Director | 04-Sep-1974 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunit Agarwal | Director | 01-Jan-1990 | Current |
| Priya Agarwal | Whole-Time Director | 05-Aug-2015 | Current |
Financial Performance of New India Chemical Pharmaceutical Works.
New India Chemical Pharmaceutical Works Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of New India Chemical Pharmaceutical Works?
In 2017, New India Chemical Pharmaceutical Works had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mayur Auto Private LimitedActive 44 years 5 monthsSunit Agarwal and Dharm Agarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at New India Chemical Pharmaceutical Works?
Unlock and access historical data on people associated with New India Chemical Pharmaceutical Works, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of New India Chemical Pharmaceutical Works, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New India Chemical Pharmaceutical Works's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
